Human immunodeficiency virus (HIV) causes immune dysregulation, potentially affecting response to vaccines in infected persons. We investigated if unexpected adverse events (AEs) or unusual patterns of AEs after vaccination were reported among HIV-positive persons. We searched for domestic reports among HIV-positive persons to the Vaccine Adverse Event Reporting System (VAERS) during 1990-2016. We analyzed reports by age group (<19 and ≥19 years), sex, serious or non-serious status, live vaccine type (live versus inactivated), AEs reported, and CD4 counts. Of 532,235 reports received, 353 (0.07%) described HIV-positive persons, of whom 67% were aged ≥19 years, and 57% were male; most reports (75%) were non-serious. The most commonly reporte...
BACKGROUND: Yellow fever vaccine (17DV) has been investigated incompletely in human immunodeficiency...
BACKGROUND: Yellow fever vaccine (17DV) has been investigated incompletely in human immunodeficiency...
The aim of this study was to assess the immunogenicity of SARS-CoV-2 available vaccines among people...
Human immunodeficiency virus (HIV) causes immune dysregulation, potentially affecting response to va...
Background: Recently, more clinical trials are being conducted in Africa and Asia, therefore, backgr...
Although annual influenza vaccination is recommended for persons who are infected with human immunod...
Background: Vaccine-induced antibodies to envelope proteins frequently cause HIV seroconversion in u...
Pneumococcal polysaccharide vaccination may be associated with adverse outcomes in HIV-infected indi...
International audienceBackground: The ANRS COV1-COHVAC cohort was a long-term safety cohort of healt...
HIV-infected patients are at increased risk for both vaccine-preventable diseases and their complica...
The immunogenicity of 2009 pandemic influenza A(H1N1) (pH1N1) vaccines and the effect of previous in...
Background: Whether seroresponse to a vaccine such as hepatitis B virus (HBV) vaccine can provide a ...
Influenza can cause severe complications in HIV infected individuals leading to increases in hospita...
The immunogenicity of 2009 pandemic influenza A(H1N1) (pH1N1) vaccines and the effect of previous in...
Context: The advancement and development of new drugs and treatment strategies increase the risk of ...
BACKGROUND: Yellow fever vaccine (17DV) has been investigated incompletely in human immunodeficiency...
BACKGROUND: Yellow fever vaccine (17DV) has been investigated incompletely in human immunodeficiency...
The aim of this study was to assess the immunogenicity of SARS-CoV-2 available vaccines among people...
Human immunodeficiency virus (HIV) causes immune dysregulation, potentially affecting response to va...
Background: Recently, more clinical trials are being conducted in Africa and Asia, therefore, backgr...
Although annual influenza vaccination is recommended for persons who are infected with human immunod...
Background: Vaccine-induced antibodies to envelope proteins frequently cause HIV seroconversion in u...
Pneumococcal polysaccharide vaccination may be associated with adverse outcomes in HIV-infected indi...
International audienceBackground: The ANRS COV1-COHVAC cohort was a long-term safety cohort of healt...
HIV-infected patients are at increased risk for both vaccine-preventable diseases and their complica...
The immunogenicity of 2009 pandemic influenza A(H1N1) (pH1N1) vaccines and the effect of previous in...
Background: Whether seroresponse to a vaccine such as hepatitis B virus (HBV) vaccine can provide a ...
Influenza can cause severe complications in HIV infected individuals leading to increases in hospita...
The immunogenicity of 2009 pandemic influenza A(H1N1) (pH1N1) vaccines and the effect of previous in...
Context: The advancement and development of new drugs and treatment strategies increase the risk of ...
BACKGROUND: Yellow fever vaccine (17DV) has been investigated incompletely in human immunodeficiency...
BACKGROUND: Yellow fever vaccine (17DV) has been investigated incompletely in human immunodeficiency...
The aim of this study was to assess the immunogenicity of SARS-CoV-2 available vaccines among people...